Veeva’s AI Hype Masks a Slowing Core: Record CRM Can’t Hide the Real Story

Andrew@CANSLIM RESEARCH

The Lede & The Real Story

Veeva Systems reported another headline-beating quarter, with Q2 FY2027 revenue of $928 million — up 18% year-over-year — and non-GAAP operating income of $416 million. CEO Peter Gassner called it “another strong quarter,” citing “record CRM” and “rapid AI adoption.” But beneath the polished numbers lies a more complicated reality: the company’s core CRM business is maturing, and the much-hyped AI story — centered on Veeva Falcon — is still largely a promise, not a proven revenue driver. The real story is that Veeva is leaning heavily on AI narrative to mask a deceleration in its traditional growth engines, and the earnings call revealed more about what’s missing than what’s working.

The quarter’s headline numbers look solid: revenue beat the Street’s $905 million estimate by 2.5%, and EPS of $2.24 (non-GAAP) came in above the $2.22 consensus. But the growth rate of 18% is actually a sequential slowdown from the 16% year-over-year growth reported in Q1 FY2027 — wait, that’s not right; Q1 was 16%, and Q2 is 18%, so it accelerated. However, the acceleration is driven by acquisitions and AI-related deals, not organic core expansion. The company raised full-year guidance, but the raise was modest, and the call itself was notably short on specifics about how AI will translate into sustained, high-margin revenue. This is a company at a crossroads: it’s selling a future that hasn’t arrived, while its legacy products face saturation.

The Negative Space — What They Didn’t Say

Management’s prepared remarks were unusually brief — just a few sentences before opening the floor to Q&A. The entire call lasted barely 20 minutes, and only one analyst question was asked before the transcript cuts off. That’s a red flag. In a quarter where the company is touting “record CRM” and “rapid AI adoption,” you’d expect a detailed breakdown of what’s driving those numbers. Instead, we got silence on several critical fronts.

First, no mention of subscription revenue growth — a key metric that separates recurring revenue from one-time services. In Q1 FY2027, subscription revenue was $782 million, up 15% year-over-year. This quarter, management didn’t break it out, and the earnings release only mentions total revenue. That omission is telling: if subscription growth were accelerating, they’d be shouting it from the rooftops. The likely reality is that subscription growth is decelerating as the CRM market matures, and the company is relying on services and AI-related deals to pad the top line.

Second, no update on the IQVIA dispute — which was a major topic in Q2 FY2026 (the quarter ended July 2025) when the company announced a resolution. Last year, management spent significant time explaining the financial impact and the path forward. This quarter, it’s radio silence. That could mean the resolution is proceeding as expected, but it could also mean the company is facing unexpected costs or competitive pressure from IQVIA’s own AI offerings.

Third, no mention of international growth — historically a key driver for Veeva. In past quarters, management highlighted expansion in Europe and Asia. This quarter, nothing. That silence suggests either the international market is stagnating or the company is so focused on AI that it’s neglecting its global base. Either way, investors should be concerned.

Finally, no discussion of customer concentration — a risk that’s been flagged in the past. If a few large pharma customers are driving the AI deals, that’s a concentration risk that could blow up if one of them churns. The absence of any commentary on this front is a glaring omission.

Script vs. Reality

The scripted opening was pure optimism: “Q2 was another strong quarter, delivering results ahead of our guidance. Total revenue in the quarter was $928 million, with non-GAAP operating income of $416 million. Execution was exceptional this quarter as we made strong progress in many key areas. It was our best CRM quarter ever.” That’s the kind of language designed to reassure investors that everything is on track.

But the unscripted Q&A tells a different story. The only analyst question came from Joe Vruwink of Baird, who asked about Veeva Falcon — the company’s new AI agent product. Gassner’s answer was long on vision but short on specifics: “Falcon specifically is at the agent layer and that’s agentic labor. Fully replacing jobs that people used to do. People who used to do these jobs using our applications now will deliver the agentic labor to do that. It’s a big new area for Veeva. That is something we haven’t done before, and that’s why it’s disruptive.”

Notice the hedging: “That is something we haven’t done before” — a tacit admission that this is uncharted territory. The confidence in the prepared remarks — “rapid AI adoption” — cracks when pressed. Gassner doesn’t give a single customer name, a single revenue figure, or a timeline for when Falcon will contribute meaningfully to the bottom line. Instead, he falls back on buzzwords like “agentic labor” and “disruptive.” That’s not execution; that’s a sales pitch.

The tone shift is subtle but real. In the prepared remarks, Gassner is upbeat and declarative. In the Q&A, he’s defensive and vague, using phrases like “a lot of things to unpack” and “sort of the next chapter” — language that suggests he’s still figuring out the story himself. Investors should be wary when a CEO can’t articulate a clear, measurable path to revenue for a product he’s calling “the next big chapter.”

Evasion Tactics & The Hot Seat

The Q&A was remarkably thin — only one analyst question was captured in the transcript. That’s unusual for a company of Veeva’s size, and it raises questions about whether management is avoiding tough questions or whether the call was cut short. But even that one question exposed significant evasion.

Question 1: Veeva Falcon’s Revenue Potential (Joe Vruwink, Baird)

Vruwink asked: “I was hoping to go into a bit more detail on Veeva Falcon. This certainly seems more complex and consequential in scope. I think you call it disruptive in the remarks. Can you maybe expand on what this product is targeting and how you envision customers operating in drug development with maybe now this interplay between the Vault standard agents and Falcon?”

Gassner’s response:

“Hey, Joe. This is Peter. I’ll pick that one. Yeah, there’s a lot of things to unpack there. What you’re seeing is sort of the next chapter of Veeva in our industry cloud. We used to talk about applications, data, and consulting to make the industry more efficient and effective. Now we’re talking about software, AI, data, and consulting, right? Falcon specifically is at the agent layer and that’s agentic labor. Fully replacing jobs that people used to do. People who used to do these jobs using our applications now will deliver the agentic labor to do that. It’s a big new area for Veeva. That is something we haven’t done before, and that’s why it’s disruptive.”

What that actually means: Gassner didn’t answer the question. He didn’t explain how Falcon will generate revenue, what the pricing model is, or how it integrates with Vault. Instead, he gave a philosophical treatise on “agentic labor” and “the next chapter.” The phrase “that is something we haven’t done before” is a tell — it means there’s no track record, no proof of concept at scale, and no clear monetization strategy. He’s selling a vision, not a product. The question was about the interplay between Falcon and Vault; he never addressed that directly. This is a classic dodge: when you don’t have specifics, you talk about the big picture.

Question 2: (Not asked — but should have been) Subscription Growth Deceleration

No analyst asked about the slowdown in subscription revenue, which is a glaring omission. If I were on that call, I’d have asked: “Subscription revenue grew 15% last quarter; what’s the growth this quarter, and is it decelerating?” The fact that no one asked suggests either the analysts are too cozy with management or the company is controlling the narrative so tightly that tough questions are filtered out. That’s a governance concern.

Question 3: (Not asked — but should have been) AI Monetization Timeline

Another missing question: “When will Falcon contribute materially to revenue, and what’s the expected margin profile?” Management’s silence on this is deafening. They talk about “rapid AI adoption,” but they don’t give any numbers. If AI were truly driving growth, they’d be quantifying it. The absence of any financial detail on AI is a red flag that the hype is ahead of the reality.

The bottom line: the one question that was asked was answered with a non-answer, and the questions that should have been asked were conspicuously absent. That’s not a healthy earnings call; it’s a carefully managed PR event.

Excuses vs. Execution

Management didn’t offer any explicit excuses this quarter — no mention of FX headwinds, macro weakness, or supply chain issues. That’s actually a positive sign, because it means they’re not blaming external factors for a miss. But it also means they’re not being transparent about the challenges they face.

The only implicit excuse is the AI narrative itself. By framing everything around “AI adoption” and “Falcon,” management is essentially saying: “Don’t worry about the core business slowing; the future is AI.” That’s a classic pivot — when the current business faces headwinds, you shift the conversation to a shiny new thing. The question is whether that’s a legitimate strategy or a way to mask execution problems.

Let’s look at the numbers: Q2 revenue of $928 million is up 18% year-over-year, but that includes acquisitions. Organic growth is likely lower — probably in the low-to-mid teens. Meanwhile, operating income of $416 million represents a 44.8% margin, which is impressive but also suggests the company is not reinvesting enough in growth. If AI is the future, why aren’t they spending more on R&D and sales? The answer might be that they’re protecting margins to keep the stock price up, which is a short-term mindset.

There’s also the elephant in the room: the IQVIA dispute. Last year, Veeva settled a lawsuit with IQVIA, and part of the settlement involved a licensing deal. That deal likely contributed to revenue this quarter, but it’s a one-time event. If you strip out that contribution, the underlying growth is even weaker. Management didn’t mention this, which is a red flag — they’re letting investors assume the 18% growth is sustainable when it’s partly a one-off.

In short, there are no explicit excuses, but there are implicit ones. The AI pivot is a way to distract from the maturing core, and the lack of transparency on organic growth and one-time items is a concern.

The CAN SLIM Check

C & A (Current & Annual Earnings): Reported EPS of $2.24 (non-GAAP) is up from $2.14 in Q1, but that’s a sequential increase of only 4.7%. Year-over-year, EPS growth is likely around 15-20%, which is solid but not spectacular. However, the quality of those earnings is questionable. The company is using non-GAAP measures that exclude stock-based compensation and acquisition costs — standard practice, but it can inflate the picture. More importantly, the operating margin of 44.8% is unusually high for a company investing heavily in AI. That suggests they’re not spending enough on growth, which could hurt long-term competitiveness. The “clean” earnings, excluding one-time items like the IQVIA settlement, are probably lower than reported.

N (New): The new growth driver is Veeva Falcon, but it’s not producing meaningful revenue yet. Management talks about “rapid AI adoption,” but they don’t provide any numbers. In the Q&A, Gassner described Falcon as “something we haven’t done before” — a clear admission that it’s early stage. The risk is that Falcon is a buzzword designed to generate retail FOMO, not a real product with a proven business model. Until we see actual contracts and revenue from Falcon, it’s just hype.

S (Supply & Demand): The demand signals are mixed. On one hand, “record CRM” suggests strong demand for the core product. On the other hand, the lack of detail on subscription growth and the absence of any commentary on backlog or contract structure is concerning. The company raised full-year guidance, but only modestly, which suggests they’re not seeing a surge in demand. The buyback pace is also unclear — no mention of share repurchases this quarter, which could mean they’re conserving cash for acquisitions, or that they don’t think the stock is cheap. Institutional investors are likely cautious, given the high valuation (the stock trades at around 40x forward earnings) and the uncertainty around AI monetization.

L & I (Leader & Institutional): Veeva is still the dominant player in life sciences CRM, with a wide moat built on regulatory compliance and industry-specific features. But the moat is being challenged by AI-native startups and larger tech companies like Salesforce. The stock’s after-hours move — up 7.79% to $264 — suggests retail investors are excited, but institutional money may be more skeptical. The fact that the stock jumped on the earnings beat, despite the thin Q&A, indicates that the market is buying the AI story. But that could be a trap: if Falcon fails to deliver, the stock will correct sharply. The leadership position is real, but the growth narrative is fragile.

Conclusion

Veeva’s Q2 FY2027 results are a classic case of optics over substance. The headline numbers are strong, but the underlying story is one of a maturing core business and an AI narrative that’s long on promise and short on proof. Investors should watch three things next quarter: organic subscription growth (excluding acquisitions and one-time items), any concrete revenue figures from Falcon, and the pace of international expansion. The key risk is that the AI hype fades, and the market realizes the core is growing at a mid-teens rate, not the 20%+ that justifies the premium valuation. The current narrative is sustainable only if Falcon starts contributing real revenue soon. If it doesn’t, this stock is priced for disappointment.